Clinical Trial Update: Caroverin and Inner Ear Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial of Caroverin for tinnitus has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Caroverin

Snippet

Sponsor: Phafag AG | Conditions: Tinnitus | Phase 3 | Status: SUSPENDED